Trial Profile
Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms ELDA
- Sponsors Sanofi
- 01 Aug 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual patient number changed from 101 to 300 as reported by ClinicalTrials.gov.
- 12 Jul 2012 Planned end date changed from 1 Jun 2010 to 1 Jun 2013 as reported by ClinicalTrials.gov.